PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Effect of prostatic adenectomy on blood clotting and fibrynolysis systems
Article published in Urologia Polska 1981/34/1.

authors

Jerzy Niemirowicz
Klinika Urologiczna Instytutu Chirurgii AMG
Kierownik Kliniki: prof. dr hab. K. Adamkiewicz
Dyrektor Instytutu: doc. dr hab. K. Lewicki

summary

Prostate is an organ containing large amounts of tissue thromboplastins and tissue plasminogen activators. The release of these substances into the blood stream after operation can cause serious disturbances in the blood equilibrium of the patient. In view of this investigations were carried out for determining the effect of surgical removal of prostatic adenoma on the blood clotting and fibrinolysis systems. The investigations were carried out in 50 patients. A statistic-ally significant increase in the processes of clotting artd fibrinolysis was observed within the first 24 hours after the operation. Besides that, attention is called to the importance of investigation of the blood clotting and fibrinolysis systems for prevention of bleeding tender.cy and thrombotic complications.

references

  1. Ambroż W., Kuźnik Z., Polubieć A.: Skaza fibrynolityczna po operacjach na gruczole krokowym. Pol. Przeg. Chir., 1967, 39, 1098.
  2. Astrup T., Thorsen S.: The physiology of fibrinolysis. Med. Clin. N. Amer., 1972, 56, 153.
  3. Bowie E. J. W., Owen C. A.: Introdiction. Symposium of the diagriosis — fibrinolysis (ICF) syndrom, with special emphasis on this syndrome in patient with cancer. Mayo. Clin. Proc, 1974, 49, 635.
  4. Bulanda B., Cencora A., Janda R., Krakowski .7., Obuczowicz M., Bulanda J.: Przewlekła hyperfibrynoliza stercza i nerkowa.
  5. Didisheim P.: The intravascular coagulation and fibrinolysis (ICF) syndrome. Trombos. Diathes. haemorrh. Suppl., 1971, 46, 119.
  6. Dobrzęcki W., Lorenz ,J.: Ostry zespół fibrynolityczna po usunięciu gruczolaka stercza. Pol. Tyg. Lek. 1965, 20, 1333.
  7. Gaertner H.: Hemostaza i krzepnięcie krwi. AM Kraków. Kraków 1970.
  8. Gormsen J., Hansen J.: Coexistence of hypercogulability and hyper-fłbrinolysis in vitro following prostatectomy for bening hypertrophy. Acta. Chir. Scand., 1961, 122, 6, 471.
  9. Januszko T., Dubińska L.: Estimation of activator of fibrinolysis by means of the euglobulin test. Acta. Med. Polona., 1965, 6', 269.
  10. Jasper W. S.: Anticoagulants in open prostatectomies. J. Urol. 1977, 117, 1, 72.
  11. Kestner R. C: Plasminogen activator in the human prostatae. J. Clin. Path., 1969, 22, 442.
  12. Kursh E. D., Ratnoff O. D., Persky L.: Current clotting concepts in urology. J. Urol., 1976, 116 (2), 214.
  13. Lombardo L. .7.: Fibrinolysis following prostatae surgery. J. Urol. 1957, 77, 289.
  14. Martens B. F., Geene L. F., Bowie E. J. W., Elveback L. R., Owen Ch. A.: Fibrinolytic Split Products (FSP) and Ethanol Gelation Test in preoperative evaluation of patients with prostatic disease Mayc Clinic. Proc, 1974, 49, 9, 642.
  15. Niewiarawski S.: Krzepnięcie krwi. PZWL Warszawa 1960.
  16. Plewiński J.: Krzepnięcie krwi po usunięciu gruczolaka stercza. Pol. Przeg. Chir., 1964, 36. 1273.
  17. Rampling M. W., Gafjney P. J.: The sulphite prećipitation method for fibrynogen measurment; it's use on smali samples in the presence of fibririogen degraciation produts. Clin. Chim. Acta., 1976, 67, 43.
  18. Rapaport S. J., Chapman C. G.: Goexiastent and acute hypofibrinogenemia in a patient with prostatic carcinoma. Amer. J. Med., 1959, 27, 144.
  19. Tagnon H., Whitmore W., Schuman N.: Fibrinolysis im meta-static cancer of the prostatae. Cancer 1952, 5, 9.
  20. Woljart H., Farbiszewski R,: Zaburzenia w układzie krzepnięcia krwi i fibrynolizy po operacjach na gruczole krokowym. Pol. Przeg. Chir., 1971, 43, 2a, 321.